SlideShare a Scribd company logo
PYREXIA OF
UNKNOWN ORIGIN
INTRODUCTION
Body temperature is normally maintained within a range of 37 – 38°c ,
normal body temperature is generally considered to be 37°c .
BODY TEMPERATURE
PHYSIOLOGY
Normal body temperature is
maintained by a complex regulatory
system in the anterior hypothalamus,
preoptic area, temperature sensitive
area, thermal set point.
PATHOGENESIS
Substances the mediate the elevation of core body temperature
There are two types; exogenous and endogenous pyrogens.
PYROGENS
EXOGENOUS PYROGENS
 It is derived from outside of the host, such as microorganisms, toxins and
microbial products
 They are generally large molecules – cannot pass blood brain barrier
 They induce the release of endogenous pyrogens from macrophages.
PATHOGENESIS
ENDOGENOUS PYROGENS
 Endogenous pyrogens are derived from the macrophages.
 They are small molecules – can pass blood brain barrier
 Pyrogen cytokines trigger the
hypothalamus to release PGE2,
resulting in:
1. Resetting of thermostatic
temperature
2. Activation of vasomotor center
3. Vasodilatation
4. Heat production
PYREXIA OF UNKNOWN ORIGIN
ORIGINAL DEFINITION (Petersdotf anf Beeson, 1961)
 Temperature ≥ 38.3ºC (101ºF) on several occasions
 Fever ≥ 3 weeks
 Failure to reach a diagnosis despite 1 week of inpatient investigations or
3 outpatient visits
NEW DEFINITION (Petersdotf anf Beeson, 1961)
Temperature ≥ 38.3ºC (101ºF) lasting for more than 14 days without an
obvious cause despite a complete history, physical examination and routine
screening with laboratory evaluation
FACTORS
FACTORS THAT MAY HAVE CONTRIBUTED TO
THE DIFFICULTY IN FINDING THE CAUSE OF FEVER INCLUDE:
 A common illness that does not have the usual symptoms – may be
asymptomatic
 Illness whose symptoms appear later
 Illnesses with possibly delayed positive test
 Person is unable to communicate about other symptoms
 Genetic condition that causes periodic fever.
COMMON CAUSES
COMMON CAUSES OF PYREXIA OF UNKNOWN ORIGIN
40%
25%
15%
10%
10%
Infection (40%) Malignancy (25%)
Autoimmune Disease (15%) Others/ Miscellaneous (10%)
Undiagnosed (10%)
CLASSIFICATION
DURACK AND STREET’S CLASSIFICATION
1. Classical
2. Nosocomial
3. Neutropenic
4. Pyrexia of unknown origin with HIV infection
CLASSIFICATION
1. CLASSICAL
CLASSIC PYREXIA OF UNKNOWN ORIGIN
 Temperature >38.3°C (100.9°F)
 Duration of >3 weeks
 Evaluation of at least 3 outpatient visits or 3 days in hospital
AETIOLOGIES
1. Infections
2. Malignancies
3. Collagen vascular disease
4. Others / miscellaneous which includes drug-induced fever
1. CLASSICAL
A. INFECTIONS
 Bacterial
Abscesses, tuberculosis, uncomplicated UTI, endocarditis, osteomyelitis,
sinusitis, prostatitis, cholecystitis, empyema, biliary tract infection,
brucellosis, typhoid, etc.
 Viral
Cytomegalovirus, infectious mononucleosis, HIV, etc.
 Parasites
Malaria, toxoplasmosis, leishmaniasis, etc.
 Fungal
Histoplasmosis, etc.
As the duration of fever increases, infectious etiology decreases. Malignancy and
factitious fevers are more common in patients with prolonged pyrexia of unknown origin
1. CLASSICAL
B. MALIGNANCIES
HEMATOLOGICAL
1. Lymphoma
2. Chronic leukemia
NON-HAEMATOLOGICAL
1. Renal cell cancer
2. Pancreatic cancer
3. Colon cancer
4. Hepatoma
1. CLASSICAL
C. COLLAGEN VASCULAR DISEASE / AUTOIMMUNE DISEASE
 Temporal arthritis
 Rheumatoid arthritis
 Rheumatoid fever
 Inflammatory bowel disease
 Reiter’s syndrome
 Systemic lupus erythematosus
 Polyarthritis nodosa
 Giant cell arthritis
 Kawasaki disease
1. CLASSICAL
C. MISCELLANEOUS
 Hyperthyroidism
 Alcoholic hepatitis
 Inflammatory bowel disease
 Deep venous thrombosis
DRUGS
 Allopurinol
 Captopril
 Cimetidine
 Clofibrate
 Erythromycin
 Heparin
 Hydralazine
 Hydrochlorothiazide
 Isoniazid
 Meperidine
 Methydopa
 Nifedipine
 Nitrofurantoin
 Penicillin
 Phenytoin
 Procainamide
 Quinidine
1. CLASSICAL
C. MISCELLANEOUS
FACTITIOUS FEVER
Central
1. Brain tumor
2. Hypothalamic dysfunction
Peripheral
3. Hyperthyroidism
4. Pheochromocytoma
Munchausen syndrome
Munchausen by proxy
THERMOREGULATORY DISORDER
FEVER PATTERN
• Intermittent Fever
 Any fever characterized by intervals of normal temperature
 Malaria, pyaemia, septicemia
• Continuous Fever
 Temperature remains above normal throughout the day and does
not fluctuate more than 1C in 24 hours
 Lobar pneumonia, Typhoid, Meningitis, UTI, Brucellosis
• Remittent Fever
 A fever pattern in which temperature varies during each 24 hour
period but never reaches normal.
 Enteric Fever, Bacterial Endocarditis, Viral Pneumonia
FEVER PATTERN
• Relapsing Fever
An acute infection with recurrent episodes of fever caused by
spirochetes of the genus Borrelia which are borne by ticks or lice.
• Undulant Fever
An infectious disease due to the bacteria Brucella.
It is called undulant because the fever is typically undulant, rising and
falling like a wave.
It is also called brucellosis after its bacterial cause
FEVER PATTERN
• Relapsing Fever
An acute infection with recurrent episodes of fever caused by
spirochetes of the genus Borrelia which are borne by ticks or lice.
• Undulant Fever
An infectious disease due to the bacteria Brucella.
It is called undulant because the fever is typically undulant, rising and
falling like a wave.
It is also called brucellosis after its bacterial cause
FEVER PATTERN
2. NOSOCOMIAL
NOSOCOMIAL PYREXIA OF UNKNOWN ORIGIN
 Temperature > 38.3°C
 Patient hospitalized ≥ 24 hours but no fever or incubating on admission
 Evaluation of at least 3 days
 More than 50% of patients with nosocomial PUO are due to infection
 Focus on sites where occult infections may be sequested, such as:
- Sinusitis of patients with NG or Oro-tracheal tubes
- Prostatic abscess in a man with urinary catheter
 25% of non-infectious cause includes:
- Acalculous colecystitis
- Deep vein thrombophlebitis
- Pulmonary embolism
3. NEUTROPENIC
IMMUNE DEFICIENT / NEUTROPENIC PUO
 Temperature >38.3°C
 Neutrophil count ≤ 500 per mm3
 Evaluation of at least 3 days
 Patients on chemotherapy or immune deficiencies are susceptible to:
- Opportunistic bacterial infection
- Fungal infections such as candidiasis
- Infections involving catheters
- Perianal infections
 Examples of etiological agent:
- Aspergillus
- Candida
- CMV
- Herpes simplex
4. HIV-ASSOCIATED
IMMUNE DEFICIENT / NEUTROPENIC PUO
 Temperature > 38.3°C
 Duration of > 4 weeks for outpatients, > 3 days for inpatients
 HIV infection confirmed
 HIV infection alone may be a cause of fever
 Common secondary causes include:
- Tuberculosis
- CMV infection
- Non-hodgkin lymphoma
- Drug-induced fever
CLINICAL APPROACH
PYREXIA OF UNKNOWN ORIGIN : A CLINICAL APPROACH
1. Onset
a. Acute
b. Gradual
2. Character
3. Antecedents
a. Dental extraction
b. Urinary catheterization
HISTORY OF PRESENTING ILLNESS
CLINICAL APPROACH
PYREXIA OF UNKNOWN ORIGIN : A CLINICAL APPROACH
4. Associated symptoms
 Chills and rigors
 Night sweats
 Loss of weight
 Cough and dyspnea
 Headache
 Joint pain
 Abdominal pain
 Bone pain
 Sore throat
 Dysuria and rectal pain
 Altered bowel habit
 Skin rash
CLINICAL APPROACH
PYREXIA OF UNKNOWN ORIGIN : A CLINICAL APPROACH
PAST MEDICAL HISTORY
PAST SURGICAL HISTORY
DRUG HISTORY
FAMILY HISTORY
CLINICAL APPROACH
PYREXIA OF UNKNOWN ORIGIN : A CLINICAL APPROACH
 Travel
 Residential area
 Occupation
 Contact with domestic / wild animals / birds
 Diet history
 Sexual orientation
 Close contact with TB patients
PHYSICAL EXAMINATION
 Pattern of fever – continuous, intermittent, relapsing
 Ill or not ill
 Weight loss – chronic illness
 Skin rash
GENERAL
HANDS
 Stigmata of infective endocarditis
 Vasculitis changes
 Clubbing
 Presence of arthropathy
 Raynaud’s phenomenon
 Drug injection sites (IV drug usage)
 Epithrochlear and axillary nodes (lymphoma, sarcoidosis, focal infection)
 Skin
ARMS
HEAD AND NECK
 Feel temporal arteries (tender and thicken)
 Eyes – iritis / conjunctivitis
 Jaundice (ascending cholangitis)
 Fundus – choroidal tubercle (miliary TB), Roth’s spot (infective
endocarditis) and retinal hemorrhage (leukemia)
 Lymphadenopathy
PHYSICAL EXAMINATION
 Butterfly rash
 Mucous membranes
 Seborrhoic dermatitis (HIV)
 Mouth ulcers (SLE)
 Buccal candidiasis
 Teeth and tonsil infections (abscess)
 Parotid enlargement
 Ears – otitis media
FACE AND MOUTH
CHEST
 Bony tenderness
 Cardiovascular – murmurs
 Respiratory – signs of pneumonia, tuberculosis, empyema and lung
cancer
PHYSICAL EXAMINATION
 Rose colored spot – typhoid fever
 Hepatomegaly
 Splenomegaly – haemopoietic malignancy, IE, malaria
 Renal enlargement – renal cell carcinoma
 Testicular enlargement – seminoma
 Penis & scrotum – discharge/rash
 Inguinal ligament
Per-rectal exam
Mass / tenderness in rectum/pelvis (abscess, carcinoma, prostatitis)
Vaginal examination
Collection of pelvic pus/ pelvic inflammatory disease
PHYSICAL EXAMINATION
ABDOMEN
 Signs of meningism (chronic TB meningitis)
 Focal neurological signs (brain abscess, mononeuritis multiplex in
plyarthritis nodosa)
PHYSICAL EXAMINATION
CENTRAL NERVOUS SYSTEM
a. Full blood count
b. ESR and CRP
c. BUSE
d. LFTs
e. Blood culture
f. Serum virology
g. Urinalysis and culture
h. Sputum culture and sensitivity
i. Stool FEME and occult blood
j. Chest x-ray
k. Mantoux test
INVESTIGATION
STAGE 1 – SCREENING TESTS
a. Repeat history and examination
b. Protein electrophoresis
c. CT (chest, abdomen, pelvis)
d. Autoantibody screen
e. Electrocardiogram (ECG)
f. Bone marrow examination
g. Lumbar puncture
h. Temporal artery biopsy
i. HIV test counselling
j. Ultrasonography
INVESTIGATION
STAGE 2
INVESTIGATION
STAGE 3
•
Tuberculosis,
malignancy,
Pneumocystis
carinii
pneumonia
Chest radiograph
•
Abscess,
malignancy
CT of abdomen or pelvis with contrast agent
•
Infection,
malignancy
Gallium 67 scan
•
Occult
septicemia
Indium-labeled leukocytes
•
Acute
infection
and
inflammation
of
bones
and
soft
tissue
Technetium Tc 99m
•
Malignancy,
autoimmune
conditions
MRI of brain
•
Malignancy,
inflammation
PET scan
•
Bacterial
endocarditis
Transthoracic or transesophageal
echocardiography
•
Venous
thrombosis
Venous Doppler study
a. Treat TB
b. Endocarditis
c. Vasculitis
d. Trial of aspirin / steroids
INVESTIGATION
STAGE 4
PUO-pyrexia of unknown origin pyrexia of unknown origin
DIAGNOSIS
 More invasive testing, such as LP or biopsy of bone
marrow, liver, or lymph nodes, should be performed
only when clinical suspicion shows that these tests are
indicated or when the source of the fever remains
unidentified after extensive evaluation.
THERAPEUTIC TRIALS
WHAT IS THE BEST THERAPEUTIC TRERAPY FOR PUO PATIENTS?
Therapeutic trials consist of combination of broad spectrum antibiotics and
are given in :-
1. Patient who is very sick to wait.
2. All tests have failed to uncover the etiology.
SUMMARY
WHAT IS THE BEST THERAPEUTIC TRERAPY FOR PUO PATIENTS?
 PUO is often a diagnostic dilemma, quandary.
 Infections comprise ~30% of cases
 Bone marrow biopsies are of low diagnostic yield
 Diagnostic approach should occur in a step-wise fashion based on the H&P
 Patient’s that remain undiagnosed generally have a good prognosis
MASTITIS
THANK YOU

More Related Content

PPTX
Pyrexia of unknown origin (PUO)
PPTX
Dndnnnssjsjjsjsjjsssjsjsjjsjsjsjsjjsjsjdn.pptx
PPTX
pyrexia of unknown origin(puo).
PPTX
Pyrexia of unknown origin
PPTX
Pyrexia of unknown origin
PPTX
Pyrexia of unknown origin (puo)
PPTX
Pyrexia of unknown origin
PPTX
Pyrexia of unknown origin edited
Pyrexia of unknown origin (PUO)
Dndnnnssjsjjsjsjjsssjsjsjjsjsjsjsjjsjsjdn.pptx
pyrexia of unknown origin(puo).
Pyrexia of unknown origin
Pyrexia of unknown origin
Pyrexia of unknown origin (puo)
Pyrexia of unknown origin
Pyrexia of unknown origin edited

Similar to PUO-pyrexia of unknown origin pyrexia of unknown origin (20)

PPTX
Fever - Dr.Rajib Hossain.pptx (Approach to a Patient with Fever)
PPTX
Fever - Dr.Rajib.pptx (Approach to a Patient with Fever)
PPTX
PPT
Fever Of Unknown Origin
PPTX
feverofunknownorigin-200601052555.pptx ppt
PPTX
Fever of unknown origin
PPTX
Pyrexia of unknown origin
PPTX
PYREXIA OF UNKNOWN ORIGIN.pptx
PPTX
FEVER OF UNKNOWN ORIGIN - PEDIATRICS
PPTX
appROACH-TO-FEBRILE-PATIENT-ppt.pptx
PPTX
ACUTE AND CHRONIC FEVER with their management
PPTX
Pyrexia of unknown origin
PPT
Pyrexia Of Unknown Origin (PUO)
PPTX
Management of Fever
PDF
approachtohistorytakinginapatientwithfever-121012050419-phpapp02.pdf
PPT
PPTX
APPROACH TO ACUTE FEBRILE ILLNESS- DIAGNOSIS AND MANAGEMENT
PPTX
Pyrexia of unknown origin
PDF
APPROACH TO FEVER AND FURTHER MANAGEMENT
PPTX
Fever - Dr.Rajib Hossain.pptx (Approach to a Patient with Fever)
Fever - Dr.Rajib.pptx (Approach to a Patient with Fever)
Fever Of Unknown Origin
feverofunknownorigin-200601052555.pptx ppt
Fever of unknown origin
Pyrexia of unknown origin
PYREXIA OF UNKNOWN ORIGIN.pptx
FEVER OF UNKNOWN ORIGIN - PEDIATRICS
appROACH-TO-FEBRILE-PATIENT-ppt.pptx
ACUTE AND CHRONIC FEVER with their management
Pyrexia of unknown origin
Pyrexia Of Unknown Origin (PUO)
Management of Fever
approachtohistorytakinginapatientwithfever-121012050419-phpapp02.pdf
APPROACH TO ACUTE FEBRILE ILLNESS- DIAGNOSIS AND MANAGEMENT
Pyrexia of unknown origin
APPROACH TO FEVER AND FURTHER MANAGEMENT
Ad

More from vikrannthv (11)

PPT
cad-stemi.pptcad-stemi.pptcad-stemi.pptcad-stemi.ppt
PPTX
meningitis - VIKRANNTH.pptxmeningitis meningitis
PDF
acid base disorder-VIKPDF.pdfacid base disorderacid base disorder
PPTX
GI MALIGNANCY-VIK.pptxGI MALIGNANCY-VIK.
PPTX
OCCUPATIONAL LUNG DISEASEnnnnnn-VIK.pptx
PPTX
Lung cancer of lung lung lung lung-vik.pptx
PPTX
Enteric cholera amoebiasis- VIKramm.pptx
PPTX
DENGUE fever management investigation treatment
PPTX
occupational lung disease management investigation treatment
PPTX
Lung cancermanagement investigation treatment
PPTX
systemicsclerosis-160704050105-converted (1).pptx
cad-stemi.pptcad-stemi.pptcad-stemi.pptcad-stemi.ppt
meningitis - VIKRANNTH.pptxmeningitis meningitis
acid base disorder-VIKPDF.pdfacid base disorderacid base disorder
GI MALIGNANCY-VIK.pptxGI MALIGNANCY-VIK.
OCCUPATIONAL LUNG DISEASEnnnnnn-VIK.pptx
Lung cancer of lung lung lung lung-vik.pptx
Enteric cholera amoebiasis- VIKramm.pptx
DENGUE fever management investigation treatment
occupational lung disease management investigation treatment
Lung cancermanagement investigation treatment
systemicsclerosis-160704050105-converted (1).pptx
Ad

Recently uploaded (20)

PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPTX
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
PPTX
LUNG ABSCESS - respiratory medicine - ppt
PPTX
post stroke aphasia rehabilitation physician
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PDF
شيت_عطا_0000000000000000000000000000.pdf
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPTX
Imaging of parasitic D. Case Discussions.pptx
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPTX
CME 2 Acute Chest Pain preentation for education
PPTX
Note on Abortion.pptx for the student note
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
OPIOID ANALGESICS AND THEIR IMPLICATIONS
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
LUNG ABSCESS - respiratory medicine - ppt
post stroke aphasia rehabilitation physician
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
شيت_عطا_0000000000000000000000000000.pdf
Medical Evidence in the Criminal Justice Delivery System in.pdf
Imaging of parasitic D. Case Discussions.pptx
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
CME 2 Acute Chest Pain preentation for education
Note on Abortion.pptx for the student note
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
Obstructive sleep apnea in orthodontics treatment
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt

PUO-pyrexia of unknown origin pyrexia of unknown origin

  • 2. INTRODUCTION Body temperature is normally maintained within a range of 37 – 38°c , normal body temperature is generally considered to be 37°c . BODY TEMPERATURE
  • 3. PHYSIOLOGY Normal body temperature is maintained by a complex regulatory system in the anterior hypothalamus, preoptic area, temperature sensitive area, thermal set point.
  • 4. PATHOGENESIS Substances the mediate the elevation of core body temperature There are two types; exogenous and endogenous pyrogens. PYROGENS EXOGENOUS PYROGENS  It is derived from outside of the host, such as microorganisms, toxins and microbial products  They are generally large molecules – cannot pass blood brain barrier  They induce the release of endogenous pyrogens from macrophages.
  • 5. PATHOGENESIS ENDOGENOUS PYROGENS  Endogenous pyrogens are derived from the macrophages.  They are small molecules – can pass blood brain barrier  Pyrogen cytokines trigger the hypothalamus to release PGE2, resulting in: 1. Resetting of thermostatic temperature 2. Activation of vasomotor center 3. Vasodilatation 4. Heat production
  • 6. PYREXIA OF UNKNOWN ORIGIN ORIGINAL DEFINITION (Petersdotf anf Beeson, 1961)  Temperature ≥ 38.3ºC (101ºF) on several occasions  Fever ≥ 3 weeks  Failure to reach a diagnosis despite 1 week of inpatient investigations or 3 outpatient visits NEW DEFINITION (Petersdotf anf Beeson, 1961) Temperature ≥ 38.3ºC (101ºF) lasting for more than 14 days without an obvious cause despite a complete history, physical examination and routine screening with laboratory evaluation
  • 7. FACTORS FACTORS THAT MAY HAVE CONTRIBUTED TO THE DIFFICULTY IN FINDING THE CAUSE OF FEVER INCLUDE:  A common illness that does not have the usual symptoms – may be asymptomatic  Illness whose symptoms appear later  Illnesses with possibly delayed positive test  Person is unable to communicate about other symptoms  Genetic condition that causes periodic fever.
  • 8. COMMON CAUSES COMMON CAUSES OF PYREXIA OF UNKNOWN ORIGIN 40% 25% 15% 10% 10% Infection (40%) Malignancy (25%) Autoimmune Disease (15%) Others/ Miscellaneous (10%) Undiagnosed (10%)
  • 9. CLASSIFICATION DURACK AND STREET’S CLASSIFICATION 1. Classical 2. Nosocomial 3. Neutropenic 4. Pyrexia of unknown origin with HIV infection
  • 11. 1. CLASSICAL CLASSIC PYREXIA OF UNKNOWN ORIGIN  Temperature >38.3°C (100.9°F)  Duration of >3 weeks  Evaluation of at least 3 outpatient visits or 3 days in hospital AETIOLOGIES 1. Infections 2. Malignancies 3. Collagen vascular disease 4. Others / miscellaneous which includes drug-induced fever
  • 12. 1. CLASSICAL A. INFECTIONS  Bacterial Abscesses, tuberculosis, uncomplicated UTI, endocarditis, osteomyelitis, sinusitis, prostatitis, cholecystitis, empyema, biliary tract infection, brucellosis, typhoid, etc.  Viral Cytomegalovirus, infectious mononucleosis, HIV, etc.  Parasites Malaria, toxoplasmosis, leishmaniasis, etc.  Fungal Histoplasmosis, etc. As the duration of fever increases, infectious etiology decreases. Malignancy and factitious fevers are more common in patients with prolonged pyrexia of unknown origin
  • 13. 1. CLASSICAL B. MALIGNANCIES HEMATOLOGICAL 1. Lymphoma 2. Chronic leukemia NON-HAEMATOLOGICAL 1. Renal cell cancer 2. Pancreatic cancer 3. Colon cancer 4. Hepatoma
  • 14. 1. CLASSICAL C. COLLAGEN VASCULAR DISEASE / AUTOIMMUNE DISEASE  Temporal arthritis  Rheumatoid arthritis  Rheumatoid fever  Inflammatory bowel disease  Reiter’s syndrome  Systemic lupus erythematosus  Polyarthritis nodosa  Giant cell arthritis  Kawasaki disease
  • 15. 1. CLASSICAL C. MISCELLANEOUS  Hyperthyroidism  Alcoholic hepatitis  Inflammatory bowel disease  Deep venous thrombosis DRUGS  Allopurinol  Captopril  Cimetidine  Clofibrate  Erythromycin  Heparin  Hydralazine  Hydrochlorothiazide  Isoniazid  Meperidine  Methydopa  Nifedipine  Nitrofurantoin  Penicillin  Phenytoin  Procainamide  Quinidine
  • 16. 1. CLASSICAL C. MISCELLANEOUS FACTITIOUS FEVER Central 1. Brain tumor 2. Hypothalamic dysfunction Peripheral 3. Hyperthyroidism 4. Pheochromocytoma Munchausen syndrome Munchausen by proxy THERMOREGULATORY DISORDER
  • 17. FEVER PATTERN • Intermittent Fever  Any fever characterized by intervals of normal temperature  Malaria, pyaemia, septicemia • Continuous Fever  Temperature remains above normal throughout the day and does not fluctuate more than 1C in 24 hours  Lobar pneumonia, Typhoid, Meningitis, UTI, Brucellosis • Remittent Fever  A fever pattern in which temperature varies during each 24 hour period but never reaches normal.  Enteric Fever, Bacterial Endocarditis, Viral Pneumonia
  • 18. FEVER PATTERN • Relapsing Fever An acute infection with recurrent episodes of fever caused by spirochetes of the genus Borrelia which are borne by ticks or lice. • Undulant Fever An infectious disease due to the bacteria Brucella. It is called undulant because the fever is typically undulant, rising and falling like a wave. It is also called brucellosis after its bacterial cause
  • 19. FEVER PATTERN • Relapsing Fever An acute infection with recurrent episodes of fever caused by spirochetes of the genus Borrelia which are borne by ticks or lice. • Undulant Fever An infectious disease due to the bacteria Brucella. It is called undulant because the fever is typically undulant, rising and falling like a wave. It is also called brucellosis after its bacterial cause
  • 21. 2. NOSOCOMIAL NOSOCOMIAL PYREXIA OF UNKNOWN ORIGIN  Temperature > 38.3°C  Patient hospitalized ≥ 24 hours but no fever or incubating on admission  Evaluation of at least 3 days  More than 50% of patients with nosocomial PUO are due to infection  Focus on sites where occult infections may be sequested, such as: - Sinusitis of patients with NG or Oro-tracheal tubes - Prostatic abscess in a man with urinary catheter  25% of non-infectious cause includes: - Acalculous colecystitis - Deep vein thrombophlebitis - Pulmonary embolism
  • 22. 3. NEUTROPENIC IMMUNE DEFICIENT / NEUTROPENIC PUO  Temperature >38.3°C  Neutrophil count ≤ 500 per mm3  Evaluation of at least 3 days  Patients on chemotherapy or immune deficiencies are susceptible to: - Opportunistic bacterial infection - Fungal infections such as candidiasis - Infections involving catheters - Perianal infections  Examples of etiological agent: - Aspergillus - Candida - CMV - Herpes simplex
  • 23. 4. HIV-ASSOCIATED IMMUNE DEFICIENT / NEUTROPENIC PUO  Temperature > 38.3°C  Duration of > 4 weeks for outpatients, > 3 days for inpatients  HIV infection confirmed  HIV infection alone may be a cause of fever  Common secondary causes include: - Tuberculosis - CMV infection - Non-hodgkin lymphoma - Drug-induced fever
  • 24. CLINICAL APPROACH PYREXIA OF UNKNOWN ORIGIN : A CLINICAL APPROACH 1. Onset a. Acute b. Gradual 2. Character 3. Antecedents a. Dental extraction b. Urinary catheterization HISTORY OF PRESENTING ILLNESS
  • 25. CLINICAL APPROACH PYREXIA OF UNKNOWN ORIGIN : A CLINICAL APPROACH 4. Associated symptoms  Chills and rigors  Night sweats  Loss of weight  Cough and dyspnea  Headache  Joint pain  Abdominal pain  Bone pain  Sore throat  Dysuria and rectal pain  Altered bowel habit  Skin rash
  • 26. CLINICAL APPROACH PYREXIA OF UNKNOWN ORIGIN : A CLINICAL APPROACH PAST MEDICAL HISTORY PAST SURGICAL HISTORY DRUG HISTORY FAMILY HISTORY
  • 27. CLINICAL APPROACH PYREXIA OF UNKNOWN ORIGIN : A CLINICAL APPROACH  Travel  Residential area  Occupation  Contact with domestic / wild animals / birds  Diet history  Sexual orientation  Close contact with TB patients
  • 28. PHYSICAL EXAMINATION  Pattern of fever – continuous, intermittent, relapsing  Ill or not ill  Weight loss – chronic illness  Skin rash GENERAL HANDS  Stigmata of infective endocarditis  Vasculitis changes  Clubbing  Presence of arthropathy  Raynaud’s phenomenon
  • 29.  Drug injection sites (IV drug usage)  Epithrochlear and axillary nodes (lymphoma, sarcoidosis, focal infection)  Skin ARMS HEAD AND NECK  Feel temporal arteries (tender and thicken)  Eyes – iritis / conjunctivitis  Jaundice (ascending cholangitis)  Fundus – choroidal tubercle (miliary TB), Roth’s spot (infective endocarditis) and retinal hemorrhage (leukemia)  Lymphadenopathy PHYSICAL EXAMINATION
  • 30.  Butterfly rash  Mucous membranes  Seborrhoic dermatitis (HIV)  Mouth ulcers (SLE)  Buccal candidiasis  Teeth and tonsil infections (abscess)  Parotid enlargement  Ears – otitis media FACE AND MOUTH CHEST  Bony tenderness  Cardiovascular – murmurs  Respiratory – signs of pneumonia, tuberculosis, empyema and lung cancer PHYSICAL EXAMINATION
  • 31.  Rose colored spot – typhoid fever  Hepatomegaly  Splenomegaly – haemopoietic malignancy, IE, malaria  Renal enlargement – renal cell carcinoma  Testicular enlargement – seminoma  Penis & scrotum – discharge/rash  Inguinal ligament Per-rectal exam Mass / tenderness in rectum/pelvis (abscess, carcinoma, prostatitis) Vaginal examination Collection of pelvic pus/ pelvic inflammatory disease PHYSICAL EXAMINATION ABDOMEN
  • 32.  Signs of meningism (chronic TB meningitis)  Focal neurological signs (brain abscess, mononeuritis multiplex in plyarthritis nodosa) PHYSICAL EXAMINATION CENTRAL NERVOUS SYSTEM
  • 33. a. Full blood count b. ESR and CRP c. BUSE d. LFTs e. Blood culture f. Serum virology g. Urinalysis and culture h. Sputum culture and sensitivity i. Stool FEME and occult blood j. Chest x-ray k. Mantoux test INVESTIGATION STAGE 1 – SCREENING TESTS
  • 34. a. Repeat history and examination b. Protein electrophoresis c. CT (chest, abdomen, pelvis) d. Autoantibody screen e. Electrocardiogram (ECG) f. Bone marrow examination g. Lumbar puncture h. Temporal artery biopsy i. HIV test counselling j. Ultrasonography INVESTIGATION STAGE 2
  • 35. INVESTIGATION STAGE 3 • Tuberculosis, malignancy, Pneumocystis carinii pneumonia Chest radiograph • Abscess, malignancy CT of abdomen or pelvis with contrast agent • Infection, malignancy Gallium 67 scan • Occult septicemia Indium-labeled leukocytes • Acute infection and inflammation of bones and soft tissue Technetium Tc 99m • Malignancy, autoimmune conditions MRI of brain • Malignancy, inflammation PET scan • Bacterial endocarditis Transthoracic or transesophageal echocardiography • Venous thrombosis Venous Doppler study
  • 36. a. Treat TB b. Endocarditis c. Vasculitis d. Trial of aspirin / steroids INVESTIGATION STAGE 4
  • 38. DIAGNOSIS  More invasive testing, such as LP or biopsy of bone marrow, liver, or lymph nodes, should be performed only when clinical suspicion shows that these tests are indicated or when the source of the fever remains unidentified after extensive evaluation.
  • 39. THERAPEUTIC TRIALS WHAT IS THE BEST THERAPEUTIC TRERAPY FOR PUO PATIENTS? Therapeutic trials consist of combination of broad spectrum antibiotics and are given in :- 1. Patient who is very sick to wait. 2. All tests have failed to uncover the etiology.
  • 40. SUMMARY WHAT IS THE BEST THERAPEUTIC TRERAPY FOR PUO PATIENTS?  PUO is often a diagnostic dilemma, quandary.  Infections comprise ~30% of cases  Bone marrow biopsies are of low diagnostic yield  Diagnostic approach should occur in a step-wise fashion based on the H&P  Patient’s that remain undiagnosed generally have a good prognosis